Rongchang Life Science (688331.SH) released its first quarter financial results, with a net loss attributable to shareholders of 254 million yuan, narrowing its losses.

Wisdom Financial APP News, Rongchang Biology (688331.SH) released the first quarter report of 2025, with the company's first quarter operating income of 526 million yuan, a year-on-year increase of 59.17%; The net loss attributable to shareholders of the listed company was 254 million yuan, narrowing the loss; The net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 252 million yuan, narrowing the loss; Basic earnings per share were -0.46 yuan/share.